Quality Assurance for Medical Devices in ChinaPacific Bridge MedicalOctober 15, 2009 SKU: PACB2621562 |
| Countries covered: China More and more medical device companies are sourcing and manufacturing their products in China. However, given recent problems with heparin, di-ethylene glycol and melamine poisoning, quality issues have become paramount. What do you need to know about QA in China to be successful and avoid pitfalls? This webcast will go over the latest regulations for medical device QA, GMP, adverse event reporting, and additional plans for quality control. A Chinese case audit will help emphasize key issues. This is a 60 minute presentation, followed by a 30-minute Q&A session. |
More China Regulation Reports
China’s Guidebook for Application and Approval of Imported In-vitro Diagnostic Reagent Registration by
Access China Management Consulting Ltd.
China is one of the fastest growing global economies with a fourth population in the world, and is one of the largest healthcare markets round ...
China’s Guidebook for Application and Approval of Imported Medical Device Registration by
Access China Management Consulting Ltd.
In 2009, the Chinese government vigorously launched “China’s Health-Care Reform”, developed an ambitious blueprint, in which health care system will cover about 1.2 billion people ...
Emerging Markets Clinical Development Series Asia (China, India, Other Emerging Asian Countries) by
Cutting Edge Information
Asia offers clinical development teams unique benefits for running trials. Among emerging markets, Asian countries offer the highest number of available patients. The region also ...
China Medical Device Regulatory Update-China Medical Webcast CD by
Pacific Bridge Medical
China’s medical device market has grown to $6 billion, the second largest in Asia after Japan. From 2004 to 2005, the number of foreign medical ...
The Medical Equipment Regulatory Scenario in BRIC Countries by
GlobalData
The Medical Equipment Regulatory Scenario in BRIC Countries Summary GlobalData viewpoints are an essential source of high quality information on all key events in the medical equipment ...
See all reports like this >>
More China Reports
D&B Country RiskLine Report: China by
Dun & Bradstreet Inc.
This D&B Country RiskLine Report will help you analyze the risks, opportunities and likely payment delays when doing business in this country. It includes ...
Country Report China February 2011 by
Economist Intelligence Unit
Country Reports analyse political and economic trends in featured countries. They show you exactly how national, regional and global events will affect your business in ...
Country Report China January 2011 by
Economist Intelligence Unit
Country Reports analyse political and economic trends in featured countries. They show you exactly how national, regional and global events will affect your business in ...
D&B Country Report: China by
Dun & Bradstreet Inc.
D&B Country Report. Comprehensive information for evaluating risks and opportunities when trading or investing in this country. Providing critical information and analysis on ...
Wine - BRIC (Brazil, Russia, India, China) Industry Guide by
MarketLine
Datamonitor's Wine - BRIC (Brazil, Russia, India, China) Industry Guide is an essential resource for top-level data and analysis covering the BRIC (Brazil, Russia, India, ...
See all reports like this >>
Related Markets
Regulation Reports
- The Neurodevice 2012 Report: Neuroprosthetics, Neuromodulation, Neurosurgery, Neurovascular Intervention and Neurosoftware
- Regulatory Intelligence on Medical Device Recalls - Ineffective Process Control, Defects in Design of Device, Software or Other Components are the Major Reasons for Recall
- Cardiac Rhythm Management Devices Market to 2017 - Technological Innovations, Regulatory Approvals and Increasing Disease Prevalence Present Growth Opportunities
- The Medical Device Market: Hong Kong
- The Medical Device Market: Venezuela
